Patients with NT-proBNP levels ≥125 pg/mL tended to be older (68 vs 58 years, P > 0.001) and were more likely to have atrial fibrillation (6.2% vs 0%, P = 0.001), heart failure (2.1% vs 0%, P = 0.11), and coronary artery disease (7.5% vs 1.3%, P = 0.004). This evidence concerns the gene NPPB and coronary artery disorder.